Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients.
作者信息
Hospital Marie-Anne, Viala Karine, Dragomir Sonia, Levy Vincent, Cohen-Aubart Fleur, Neil Jean, Musset Lucile, Choquet Sylvain, Leger Jean-Marc, Leblond Véronique
出版信息
Haematologica. 2013 Dec;98(12):e155-7. doi: 10.3324/haematol.2013.087213.
Abstract
摘要
相似文献
1
Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients.基于免疫疗法的方案治疗抗MAG神经病变：45例患者的结果
Haematologica. 2013 Dec;98(12):e155-7. doi: 10.3324/haematol.2013.087213.
2
Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.IgM 型抗髓鞘相关糖蛋白神经病患者接受利妥昔单抗联合氟达拉滨治疗的长期应答。
J Peripher Nerv Syst. 2011 Sep;16(3):180-5. doi: 10.1111/j.1529-8027.2011.00343.x.
3
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.利妥昔单抗治疗抗髓鞘相关糖蛋白（MAG）神经病患者的疗效：病例报告。
Immunopharmacol Immunotoxicol. 2013 Oct;35(5):622-4. doi: 10.3109/08923973.2013.822507. Epub 2013 Aug 15.
4
Myelin modifications in 8 cases of peripheral neuropathy with Waldenström's macroglobulinemia and anti-MAG activity.8例伴有华氏巨球蛋白血症及抗MAG活性的周围神经病的髓鞘改变
Ultrastruct Pathol. 1997 Nov-Dec;21(6):509-16. doi: 10.3109/01913129709016367.
5
Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment.利妥昔单抗治疗期间IgM抗MAG脱髓鞘性多发性神经病迅速恶化。
J Peripher Nerv Syst. 2013 Jun;18(2):189-91. doi: 10.1111/jns5.12018.
6
Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.对埃及单克隆丙种球蛋白血症患者周围神经的临床、电生理和免疫学研究。
Int J Hematol. 2012 Jan;95(1):71-6. doi: 10.1007/s12185-011-0983-8. Epub 2011 Dec 17.
7
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.IgM抗髓鞘相关糖蛋白副蛋白相关周围神经病的免疫治疗
Cochrane Database Syst Rev. 2012 May 16(5):CD002827. doi: 10.1002/14651858.CD002827.pub3.
8
Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy.利妥昔单抗治疗抗MAG神经病变患者疗效的预测因素
J Neurol Sci. 2017 Jun 15;377:144-148. doi: 10.1016/j.jns.2017.04.015. Epub 2017 Apr 12.
9
Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature.抗髓鞘相关糖蛋白抗体周围神经病对苯达莫司汀/利妥昔单抗联合化疗免疫疗法治疗双克隆IgM κ和IgM λ患者的反应：病例报告及文献综述
Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):e101-8. doi: 10.1016/j.clml.2016.04.004. Epub 2016 May 5.
10
IgM monoclonal gammopathy-associated neuropathies with different IgM specificity.伴有不同 IgM 特异性的 IgM 单克隆丙种球蛋白血症相关神经病。
Eur J Neurol. 2011 Aug;18(8):1067-73. doi: 10.1111/j.1468-1331.2010.03345.x. Epub 2011 Jan 25.
引用本文的文献
1
Monoclonal Gammopathy-Associated Neuropathy.单克隆丙种球蛋白病相关神经病
Curr Hematol Malig Rep. 2024 Dec 16;20(1):2. doi: 10.1007/s11899-024-00745-8.
2
Pathophysiology and Treatments of Complications of Waldenström's Macroglobulinemia.华氏巨球蛋白血症并发症的病理生理学与治疗方法
Clin Hematol Int. 2024 Oct 7;6(4):11-18. doi: 10.46989/001c.124268. eCollection 2024.
3
Uncommon Presentation of IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Anti-Myelin-Associated Glycoprotein (MAG)-Associated Demyelinating Peripheral Neuropathy as Respiratory Failure: A Case Report.意义未明的IgM单克隆丙种球蛋白病（MGUS）及抗髓鞘相关糖蛋白（MAG）相关脱髓鞘性周围神经病以呼吸衰竭为表现的罕见病例报告
Cureus. 2024 Jun 21;16(6):e62865. doi: 10.7759/cureus.62865. eCollection 2024 Jun.
4
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenario.当华氏巨球蛋白血症累及肾脏时：病例系列描述及“罕见中的罕见”情况的处理
Cancer Rep (Hoboken). 2024 Apr;7(4):e2062. doi: 10.1002/cnr2.2062.
5
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.从具有神经学意义的单克隆丙种球蛋白病的生物学机制到治疗方法
Cancers (Basel). 2022 Mar 18;14(6):1562. doi: 10.3390/cancers14061562.
6
Decrease in Serum Anti-MAG Autoantibodies Is Associated With Therapy Response in Patients With Anti-MAG Neuropathy: Retrospective Study.血清抗 MAG 自身抗体减少与抗 MAG 神经病患者的治疗反应相关：回顾性研究。
Neurol Neuroimmunol Neuroinflamm. 2021 Nov 10;9(1). doi: 10.1212/NXI.0000000000001109. Print 2022 Jan.
7
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.肾脏意义单克隆丙种球蛋白血症和神经意义单克隆丙种球蛋白血症的评估和管理。
Am J Hematol. 2021 Jul 1;96(7):846-853. doi: 10.1002/ajh.26155. Epub 2021 Mar 25.
8
Immunotherapy in Peripheral Neuropathies.免疫疗法在周围神经病中的应用。
Neurotherapeutics. 2016 Jan;13(1):96-107. doi: 10.1007/s13311-015-0401-7.
9
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus.华氏巨球蛋白血症（WM）及相关疾病患者的治疗建议：IWWM - 7共识
Blood. 2014 Aug 28;124(9):1404-11. doi: 10.1182/blood-2014-03-565135. Epub 2014 Jul 15.
10
Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.慢性获得性脱髓鞘性多发性神经病的诊断与治疗。
Nat Rev Neurol. 2014 Aug;10(8):435-46. doi: 10.1038/nrneurol.2014.117. Epub 2014 Jul 1.
本文引用的文献
1
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy.利妥昔单抗治疗 IgM 型抗髓鞘相关糖蛋白神经病变的安慰剂对照试验。
Neurology. 2013 Jun 11;80(24):2217-25. doi: 10.1212/WNL.0b013e318296e92b. Epub 2013 May 10.
2
Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.IgM 型抗髓鞘相关糖蛋白神经病患者接受利妥昔单抗联合氟达拉滨治疗的长期应答。
J Peripher Nerv Syst. 2011 Sep;16(3):180-5. doi: 10.1111/j.1529-8027.2011.00343.x.
3
The neuropathies of Waldenström's macroglobulinemia (WM) and IgM-MGUS.华氏巨球蛋白血症（WM）和 IgM-MGUS 的神经病变。
Can J Neurol Sci. 2011 Mar;38(2):289-95. doi: 10.1017/s0317167100011483.
4
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.欧洲神经病学会联合会/周围神经学会关于治疗副蛋白血症性脱髓鞘神经病的指南。 欧洲神经病学会联合会和周围神经学会联合工作组的报告 - 第一次修订。
J Peripher Nerv Syst. 2010 Sep;15(3):185-95. doi: 10.1111/j.1529-8027.2010.00278.x.
5
Rituximab for polyneuropathy with IgM monoclonal gammopathy.利妥昔单抗治疗伴有IgM单克隆丙种球蛋白病的多发性神经病
J Neurol Neurosurg Psychiatry. 2009 Sep;80(9):1036-9. doi: 10.1136/jnnp.2008.155325.
6
Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy.在使用基于核苷类似物的疗法治疗华氏巨球蛋白血症患者时平衡风险与获益
Clin Lymphoma Myeloma. 2009 Mar;9(1):71-3. doi: 10.3816/CLM.2009.n.018.
7
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.利妥昔单抗治疗IgM抗髓鞘相关糖蛋白抗体脱髓鞘性神经病的安慰剂对照试验
Ann Neurol. 2009 Mar;65(3):286-93. doi: 10.1002/ana.21577.
8
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.来自第四届华氏巨球蛋白血症国际研讨会的治疗建议更新
J Clin Oncol. 2009 Jan 1;27(1):120-6. doi: 10.1200/JCO.2008.17.7865. Epub 2008 Dec 1.
9
Treatment-related myelodysplasia following fludarabine combination chemotherapy.氟达拉滨联合化疗后与治疗相关的骨髓增生异常综合征
Haematologica. 2006 Nov;91(11):1546-50.
10
Anti-myelin-associated glycoprotein neuropathy.抗髓鞘相关糖蛋白神经病
Curr Opin Neurol. 2006 Oct;19(5):458-63. doi: 10.1097/01.wco.0000245368.36576.0d.
Zotero 插件